LimbuStem R&D Medical Products Ltd.

LimbuStem is a Turkish-based company that specializes in advanced therapy medicinal products (ATMPs). Supported by The Scientific and Technological Research Council of Turkey (TÜBİTAK), the company focuses on research, development, production, and delivery of innovative therapies for various medical needs. Founded in 2020, LimbuStem's current focal points are the development, production, and marketing of in vitro expanded corneal epithelial stem cells for patient-specific treatment of damaged cornea. Additionally, the company's bioengineers are dedicated to processing and preparing the human amniotic membrane for direct clinical use. Notably, all advanced therapy products are produced and processed at GMP laboratories that are fully licensed and certified in accordance with legal regulations. LimbuStem operates in the Digital Health, Health Care, Health and Wellness, and Healthtech industries, with its headquarters located in Izmir, Turkey. As of now, there is no public information available regarding the company's latest investment or the involved investors.